Blood Pressure Measurement, White-Coat and Masked Hypertension

  • G. Seravalle
  • G. Grassi
  • Giuseppe ManciaEmail author
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)


High blood pressure is the most common diagnosis in adult primary care practice and the most important cardiovascular risk factor.


  1. 1.
    Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2224–60.CrossRefGoogle Scholar
  2. 2.
    Turner JR, Viera AJ, Shimbo D. Ambulatory blood pressure monitoring in clinical practice: a review. Am J Med. 2015;128:14–20.CrossRefPubMedGoogle Scholar
  3. 3.
    Pickering T, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.CrossRefPubMedGoogle Scholar
  4. 4.
    Myers MG. Replacing manual sphygmomanometers with automated blood pressure measurement in routine clinical practice. Clin Exp Pharmacol Physiol. 2014;41:46–53.CrossRefPubMedGoogle Scholar
  5. 5.
    Andreadis EA, Angelopoulos ET, Agaliotis GD, et al. Why use automated office blood pressure measurements in clinical practice? High Blood Press Cardiovasc Prev. 2011;18:89–91.CrossRefPubMedGoogle Scholar
  6. 6.
    Imai Y. Clinical significance of home blood pressure and its possible practical application. Clin Exp Nephrol. 2014;18:24–40.CrossRefPubMedGoogle Scholar
  7. 7.
    Stergiou GS, Kollias A, Zeniodi M, et al. Home blood pressure monitoring: primary role in hypertension management. Curr Hypertens Rep. 2014;16:462.CrossRefPubMedGoogle Scholar
  8. 8.
    Parati G, Mutti E, Ravogli A, et al. Advantages and disadvantages of non-invasive ambulatory blood pressure monitoring. J Hypertens. 1990;8(suppl 6):S33–8.Google Scholar
  9. 9.
    Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.CrossRefPubMedGoogle Scholar
  10. 10.
    O’Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68.CrossRefPubMedGoogle Scholar
  11. 11.
    Villani A, Parati G, Groppelli A, et al. Noninvasive automatic blood pressure monitoring does not attenuate night-time hypotension. Am J Hypertens. 1992;5:744–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Parati G, Pomidossi G, Casadei R, Mancia G. Lack of alerting reactions to intermittent cuff inflations during non-invasive blood pressure monitoring. Hypertension. 1985;7:597–601.CrossRefPubMedGoogle Scholar
  13. 13.
    Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension. 2000;36:894–900.CrossRefPubMedGoogle Scholar
  14. 14.
    Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998;31:712–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Staessen JA, Thijs L, Fagard R, O’Brien ET, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539–46.CrossRefPubMedGoogle Scholar
  16. 16.
    Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156–61.CrossRefPubMedGoogle Scholar
  17. 17.
    Kikuya M, Hansen TW, Thijs L, et al. International Database on ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10 year cardiovascular risk. Circulation. 2007;115:2145–52.CrossRefPubMedGoogle Scholar
  18. 18.
    Zanchetti A, Bond MG, Heening M, et al. On behalf of the ELSA Study group. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Mancia G, Zanchetti A, Agabiti-Rosei et al. for the SAMPLE study group. Ambulatory blood pressure is superiori to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation. 1997;95:1464–70.CrossRefPubMedGoogle Scholar
  20. 20.
    Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805.CrossRefPubMedGoogle Scholar
  21. 21.
    Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801.CrossRefPubMedGoogle Scholar
  22. 22.
    Ohkubo T, Imai Y, Tsuji I, et al. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens. 1997;10:1201–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007;49:1265–70.CrossRefPubMedGoogle Scholar
  24. 24.
    Mancia G, Parati G, Di Rienzo M, Zanchetti A. Blood pressure variability. In: Zanchetti A, Mancia G, editors. Handbook of hypertension, vol 17: pathophysiology of hypertension. Elsevier, Amsterdam: The Netherlands; 1997. p. 117–69.Google Scholar
  25. 25.
    Mancia G. Short- and long-term blood pressure variability: present and future. Hypertension. 2012;60:512–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.CrossRefPubMedGoogle Scholar
  27. 27.
    Mancia G, Bertinieri G, Grassi G, et al. Effects of blood pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet. 1983;2:695–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Parati G, Bilo G, Mancia G. White coat effect and white coat hypertension: what do they mean? Cardiovasc Rev Rep. 2003;24:477–84.Google Scholar
  29. 29.
    Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13:1377–90.CrossRefPubMedGoogle Scholar
  30. 30.
    Staessen JA, Bieniaszewski L, O’Brien ET, Imai Y, Fagard R. An epidemiological approach to ambulatory blood pressure monitoring: the Belgian Population Study. Blood Press Monit. 1996;1:13–26.PubMedGoogle Scholar
  31. 31.
    Imai Y, Nagai K, Sakuma H, et al. Ambulatory blood pressure of adults in Ohasama. Jpn Hyperten. 1993;22:900–12.CrossRefGoogle Scholar
  32. 32.
    Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Van Hoof R, Amery AK. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol. 1991;67:723–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professionall and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142–61.CrossRefPubMedGoogle Scholar
  34. 34.
    Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Pall D, Juhasz M, Lengyel S, et al. Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. J Hypertens. 2010;28:2139–44.CrossRefPubMedGoogle Scholar
  36. 36.
    Palatini P, Mormino P, Santonastaso M, et al. Target organ damage in stage I hypertensive subjects with white coat and sustained hypertension. Results from the HARVEST study. Hypertension. 1998;32:377–8.CrossRefGoogle Scholar
  37. 37.
    Nakashima T, Yamano S, Sasaki R, et al. White-coat hypertension contributes to the presence of carotid atherosclerosis. Hypertens Res. 2004;27:739–45.CrossRefPubMedGoogle Scholar
  38. 38.
    Kostis V, Stabouli S. Toumanidis, et al Target organ damage in white-coat and masked hypertension. Am J Hypertens. 2008;21:393–9.CrossRefGoogle Scholar
  39. 39.
    Verdecchia P, Reboldi GP, Angeli F, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45:203–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Kario K, Shimada K, Schwartz JE, et al. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001;38:238–45.CrossRefPubMedGoogle Scholar
  41. 41.
    Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10 year follow-up study. J Hum Hypertens. 2003;17:811–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white coat or masked hypertension. Hypertension. 2009;54:226–32.CrossRefPubMedGoogle Scholar
  43. 43.
    Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Angeli F, Reboldi G, Verdecchia P. Masked hypertension: evaluation, prognosis, and treatment. Am J Hypertens. 2010;23:941–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Pierdomenico SD, Cuccurullo F. Prognostic values of white coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens. 2011;24:52–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of masked hypertension and white coat hypertension detected by 24-h ambulatory blood pressure monitoring 10 year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508–15.CrossRefPubMedGoogle Scholar
  47. 47.
    Smith PA, Graham LN, Mackintosh AF, et al. Sympathetic neural mechanisms in white coat hypertension. J Am Coll Cardiol. 2002;40:126–32.CrossRefPubMedGoogle Scholar
  48. 48.
    Grassi G, Seravalle G, Quarti Trevano F, et al. Neurogenic abnormalities in masked hypertension. Hypertension. 2007;50:537–42.CrossRefPubMedGoogle Scholar
  49. 49.
    Grassi G, Seravalle G, Buzzi S, et al. Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement. J Hypertens. 2013;31:1131–5.CrossRefPubMedGoogle Scholar
  50. 50.
    Ogedegbe G, Pickering TG, Clemow L, et al. The misdiagnosis of hypertension: the role of patient anxiety. Arch Intern Med. 2008;168:2459–65.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Curgunlu A, Uzun H, Bavunoglu I, et al. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens. 2005;19:629–33.CrossRefPubMedGoogle Scholar
  52. 52.
    Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 2009;54:690–7.CrossRefPubMedGoogle Scholar
  53. 53.
    Schnall PI, Schwartz JE, Landsbergis PA, Warren K, Pickering TG. Relation between job strain, alcohol, and ambulatory blood pressure. Hypertension. 1992;19:488–94.CrossRefPubMedGoogle Scholar
  54. 54.
    Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertesnive smokers. A case-control study. JAMA. 1991;265:2226–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Mancia G, Bombelli M, Brambilla G, et al. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension. 2013;62:168–74.CrossRefPubMedGoogle Scholar
  56. 56.
    Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Cardiology DepartmentIstituto Auxologico Italiano, IRCCS S. Luca HospitalMilanoItaly
  2. 2.Medical ClinicS. Gerardo Hospital, University Milano-BicoccaMonza-MilanoItaly
  3. 3.IRCCS MultimedicaMilanoItaly
  4. 4.University of Milano-BicoccaMilanItaly

Personalised recommendations